These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
457 related articles for article (PubMed ID: 12589162)
1. Inhibition of complement factor C5 protects against renal ischemia-reperfusion injury: inhibition of late apoptosis and inflammation. De Vries B; Matthijsen RA; Wolfs TG; Van Bijnen AA; Heeringa P; Buurman WA Transplantation; 2003 Feb; 75(3):375-82. PubMed ID: 12589162 [TBL] [Abstract][Full Text] [Related]
2. Predominant role for C5b-9 in renal ischemia/reperfusion injury. Zhou W; Farrar CA; Abe K; Pratt JR; Marsh JE; Wang Y; Stahl GL; Sacks SH J Clin Invest; 2000 May; 105(10):1363-71. PubMed ID: 10811844 [TBL] [Abstract][Full Text] [Related]
3. Treatment with an inhibitory monoclonal antibody to mouse factor B protects mice from induction of apoptosis and renal ischemia/reperfusion injury. Thurman JM; Royer PA; Ljubanovic D; Dursun B; Lenderink AM; Edelstein CL; Holers VM J Am Soc Nephrol; 2006 Mar; 17(3):707-15. PubMed ID: 16467447 [TBL] [Abstract][Full Text] [Related]
4. Effect of anti-C5 antibody on recuperation from ischemia/reperfusion-induced acute kidney injury. Zilberman-Itskovich S; Abu-Hamad R; Stark M; Efrati S Ren Fail; 2019 Nov; 41(1):967-975. PubMed ID: 31662004 [TBL] [Abstract][Full Text] [Related]
5. Lysophosphatidic acid prevents renal ischemia-reperfusion injury by inhibition of apoptosis and complement activation. de Vries B; Matthijsen RA; van Bijnen AA; Wolfs TG; Buurman WA Am J Pathol; 2003 Jul; 163(1):47-56. PubMed ID: 12819010 [TBL] [Abstract][Full Text] [Related]
6. The mannose-binding lectin-pathway is involved in complement activation in the course of renal ischemia-reperfusion injury. de Vries B; Walter SJ; Peutz-Kootstra CJ; Wolfs TG; van Heurn LW; Buurman WA Am J Pathol; 2004 Nov; 165(5):1677-88. PubMed ID: 15509537 [TBL] [Abstract][Full Text] [Related]
7. Protection of renal ischemia injury using combination gene silencing of complement 3 and caspase 3 genes. Zheng X; Zhang X; Sun H; Feng B; Li M; Chen G; Vladau C; Chen D; Suzuki M; Min L; Liu W; Zhong R; Garcia B; Jevnikar A; Min WP Transplantation; 2006 Dec; 82(12):1781-6. PubMed ID: 17198276 [TBL] [Abstract][Full Text] [Related]
8. Endogenous interleukin-6 enhances the renal injury, dysfunction, and inflammation caused by ischemia/reperfusion. Patel NS; Chatterjee PK; Di Paola R; Mazzon E; Britti D; De Sarro A; Cuzzocrea S; Thiemermann C J Pharmacol Exp Ther; 2005 Mar; 312(3):1170-8. PubMed ID: 15572648 [TBL] [Abstract][Full Text] [Related]
9. Mice lacking the 110-kD isoform of poly(ADP-ribose) glycohydrolase are protected against renal ischemia/reperfusion injury. Patel NS; Cortes U; Di Poala R; Mazzon E; Mota-Filipe H; Cuzzocrea S; Wang ZQ; Thiemermann C J Am Soc Nephrol; 2005 Mar; 16(3):712-9. PubMed ID: 15677308 [TBL] [Abstract][Full Text] [Related]
10. AChE deficiency or inhibition decreases apoptosis and p53 expression and protects renal function after ischemia/reperfusion. Ye W; Gong X; Xie J; Wu J; Zhang X; Ouyang Q; Zhao X; Shi Y; Zhang X Apoptosis; 2010 Apr; 15(4):474-87. PubMed ID: 20054652 [TBL] [Abstract][Full Text] [Related]
11. Vaccinia virus complement control protein (VCP) improves kidney structure and function following ischemia/reperfusion injury in rats. Ghebremariam YT; Engelbrecht G; Tyler M; Lotz Z; Govender D; Kotwal GJ; Kahn D J Surg Res; 2010 Apr; 159(2):747-54. PubMed ID: 19691975 [TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibodies directed against human C5 and C8 block complement-mediated damage of xenogeneic cells and organs. Rollins SA; Matis LA; Springhorn JP; Setter E; Wolff DW Transplantation; 1995 Dec; 60(11):1284-92. PubMed ID: 8525523 [TBL] [Abstract][Full Text] [Related]
13. Posttransplant ischemia-reperfusion injury in transplanted heart is prevented by a minibody to the fifth component of complement. Ferraresso M; Macor P; Valente M; Della Barbera M; D'Amelio F; Borghi O; Raschi E; Durigutto P; Meroni P; Tedesco F Transplantation; 2008 Nov; 86(10):1445-51. PubMed ID: 19034016 [TBL] [Abstract][Full Text] [Related]
14. A novel interpretation of immune redundancy and duality in reperfusion injury with important implications for intervention in ischaemic disease. Thrane AS; Skehan JD; Thrane PS Med Hypotheses; 2007; 68(6):1363-70. PubMed ID: 17169498 [TBL] [Abstract][Full Text] [Related]
16. Pretreatment with granulocyte colony-stimulating factor attenuated renal ischaemia and reperfusion injury via activation of PI3/Akt signal pathway. Li Y; Wu J; Shou Z; He Q; Zhang P; Han F; Li H; Chen J Nephrology (Carlton); 2008 Dec; 13(6):508-16. PubMed ID: 18331437 [TBL] [Abstract][Full Text] [Related]
17. Notoginsenoside R1 attenuates renal ischemia-reperfusion injury in rats. Liu WJ; Tang HT; Jia YT; Ma B; Fu JF; Wang Y; Lv KY; Xia ZF Shock; 2010 Sep; 34(3):314-20. PubMed ID: 20023602 [TBL] [Abstract][Full Text] [Related]
18. Role of complement component C5 in cerebral ischemia/reperfusion injury. Costa C; Zhao L; Shen Y; Su X; Hao L; Colgan SP; Stahl GL; Zhou T; Wang Y Brain Res; 2006 Jul; 1100(1):142-51. PubMed ID: 16780818 [TBL] [Abstract][Full Text] [Related]
19. Reduction of circulating redox-active iron by apotransferrin protects against renal ischemia-reperfusion injury. de Vries B; Walter SJ; von Bonsdorff L; Wolfs TG; van Heurn LW; Parkkinen J; Buurman WA Transplantation; 2004 Mar; 77(5):669-75. PubMed ID: 15021827 [TBL] [Abstract][Full Text] [Related]
20. The effect of C1 inhibitor on intestinal ischemia and reperfusion injury. Lu F; Chauhan AK; Fernandes SM; Walsh MT; Wagner DD; Davis AE Am J Physiol Gastrointest Liver Physiol; 2008 Nov; 295(5):G1042-9. PubMed ID: 18787060 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]